[BRNS] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[BRNS] Barinthus Biotherapeutics plc
Announcement Date
29-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 40.88%
YoY- -270.74%
Quarter Report
BRNS's Result
BRNS's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 5,369 0 334 468 6,457 -
PBT -17,663 -16,142 -18,268 -14,713 -24,960 -18,739 -23,182 -16.59%
Tax -701 -631 -827 -603 -1,136 -516 -2,019 -50.63%
NP -16,950 -15,480 -17,443 -14,072 -23,802 -18,180 -21,189 -13.83%
Tax Rate - - - - - - - -
Total Cost 16,950 15,480 22,813 14,072 24,136 18,648 27,646 -27.85%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -324.88 0.00 -7,126.35 -3,884.62 -328.16 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.43 -0.40 -0.45 -0.37 -0.62 -0.48 -0.56 -16.16%
EPS Diluted -0.43 -0.40 -0.45 -0.37 -0.62 -0.48 -0.56 -16.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.